Edward Gershburg

1.4k total citations
29 papers, 1.1k citations indexed

About

Edward Gershburg is a scholar working on Epidemiology, Oncology and Molecular Biology. According to data from OpenAlex, Edward Gershburg has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 14 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Edward Gershburg's work include Herpesvirus Infections and Treatments (14 papers), Viral-associated cancers and disorders (14 papers) and Cytomegalovirus and herpesvirus research (14 papers). Edward Gershburg is often cited by papers focused on Herpesvirus Infections and Treatments (14 papers), Viral-associated cancers and disorders (14 papers) and Cytomegalovirus and herpesvirus research (14 papers). Edward Gershburg collaborates with scholars based in United States, Germany and Israel. Edward Gershburg's co-authors include Joseph S. Pagano, Nor Chejanovsky, William P. Halford, Svetlana Gershburg, Shannon C. Kenney, Stacy R. Hagemeier, Joyce D. Fingeroth, Meng Qiao, Maria Rosaria Torrisi and Salvatore Raffa and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Edward Gershburg

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Gershburg United States 19 575 524 368 209 124 29 1.1k
Noriko Shirata Japan 14 418 0.7× 418 0.8× 367 1.0× 118 0.6× 50 0.4× 16 821
Satoko Iwahori Japan 21 458 0.8× 442 0.8× 366 1.0× 134 0.6× 60 0.5× 31 922
Wilma P. Summers United States 17 525 0.9× 366 0.7× 334 0.9× 163 0.8× 140 1.1× 27 1.0k
Shihua Lu United States 7 322 0.6× 487 0.9× 1.0k 2.8× 212 1.0× 80 0.6× 9 1.6k
Harinivas H. Krishnan United States 10 698 1.2× 797 1.5× 208 0.6× 261 1.2× 142 1.1× 10 1.2k
Sanae Nakayama Japan 17 430 0.7× 392 0.7× 285 0.8× 145 0.7× 58 0.5× 22 775
Gregory S. Pari United States 25 1.4k 2.4× 729 1.4× 496 1.3× 182 0.9× 44 0.4× 44 1.8k
Mira S. Chaurushiya United States 9 332 0.6× 232 0.4× 362 1.0× 201 1.0× 26 0.2× 9 728
Daniëlle Horst Netherlands 15 371 0.6× 444 0.8× 186 0.5× 452 2.2× 113 0.9× 17 901
Li–Rung Huang Taiwan 15 717 1.2× 206 0.4× 370 1.0× 569 2.7× 12 0.1× 27 1.4k

Countries citing papers authored by Edward Gershburg

Since Specialization
Citations

This map shows the geographic impact of Edward Gershburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Gershburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Gershburg more than expected).

Fields of papers citing papers by Edward Gershburg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Gershburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Gershburg. The network helps show where Edward Gershburg may publish in the future.

Co-authorship network of co-authors of Edward Gershburg

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Gershburg. A scholar is included among the top collaborators of Edward Gershburg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Gershburg. Edward Gershburg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plotkin, Stanley A., James M. Robinson, Joseph R A Fitchett, & Edward Gershburg. (2024). Vaccine Development Should Be Polytheistic, Not Monotheistic. Clinical Infectious Diseases. 79(6). 1518–1520. 1 indexed citations
2.
Stanfield, Brent, et al.. (2021). Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses. Viruses. 13(8). 1637–1637. 23 indexed citations
3.
Chambers, Christopher B., et al.. (2015). A System for Creating Stable Cell Lines that Express a Gene of Interest from a Bidirectional and Regulatable Herpes Simplex Virus Type 1 Promoter. PLoS ONE. 10(3). e0122253–e0122253. 5 indexed citations
4.
Gershburg, Svetlana, et al.. (2015). The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious Virions. PLoS ONE. 10(6). e0131420–e0131420. 17 indexed citations
5.
Gershburg, Edward, et al.. (2015). Herpes Simplex Virus 2 (HSV-2) Infected Cell Proteins Are among the Most Dominant Antigens of a Live-Attenuated HSV-2 Vaccine. PLoS ONE. 10(2). e0116091–e0116091. 15 indexed citations
6.
Halford, William P., et al.. (2013). Pan-HSV-2 IgG Antibody in Vaccinated Mice and Guinea Pigs Correlates with Protection against Herpes Simplex Virus 2. PLoS ONE. 8(6). e65523–e65523. 19 indexed citations
7.
Goswami, Ria, et al.. (2012). Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein–Barr virus. Antiviral Research. 96(3). 296–304. 31 indexed citations
8.
9.
Gershburg, Edward, et al.. (2010). ICP0 Antagonizes ICP4-Dependent Silencing of the Herpes Simplex Virus ICP0 Gene. PLoS ONE. 5(1). e8837–e8837. 13 indexed citations
10.
Whitehurst, Christopher B., Shunbin Ning, Gretchen L. Bentz, et al.. (2009). The Epstein-Barr Virus (EBV) Deubiquitinating Enzyme BPLF1 Reduces EBV Ribonucleotide Reductase Activity. Journal of Virology. 83(9). 4345–4353. 61 indexed citations
11.
Roy, Debasmita, et al.. (2009). Maribavir Inhibits Epstein-Barr Virus Transcription in Addition to Viral DNA Replication. Journal of Virology. 83(23). 12108–12117. 33 indexed citations
12.
Gershburg, Edward, Salvatore Raffa, Maria Rosaria Torrisi, & Joseph S. Pagano. (2007). Epstein-Barr Virus-Encoded Protein Kinase (BGLF4) Is Involved in Production of Infectious Virus. Journal of Virology. 81(10). 5407–5412. 72 indexed citations
13.
Yue, Wei, Edward Gershburg, & Joseph S. Pagano. (2005). Hyperphosphorylation of EBNA2 by Epstein-Barr Virus Protein Kinase Suppresses Transactivation of the LMP1 Promoter. Journal of Virology. 79(9). 5880–5885. 48 indexed citations
14.
Gershburg, Edward & Joseph S. Pagano. (2005). Epstein–Barr virus infections: prospects for treatment. Journal of Antimicrobial Chemotherapy. 56(2). 277–281. 79 indexed citations
15.
Regev, Avital, Bora İnceoğlu, Edward Gershburg, et al.. (2003). Further enhancement of baculovirus insecticidal efficacy with scorpion toxins that interact cooperatively. FEBS Letters. 537(1-3). 106–110. 45 indexed citations
16.
Zacny, Valerie, Edward Gershburg, Michelle G. Davis, Karen K. Biron, & Joseph S. Pagano. (1999). Inhibition of Epstein-Barr Virus Replication by a Benzimidazole l -Riboside: Novel Antiviral Mechanism of 5,6-Dichloro-2-(Isopropylamino)-1-β- l -Ribofuranosyl-1H-Benzimidazole. Journal of Virology. 73(9). 7271–7277. 60 indexed citations
17.
Gurevitz, Michael, Oren Froy, Noam Zilberberg, et al.. (1998). Sodium channel modifiers from scorpion venom: Structure–activity relationship, mode of action and application. Toxicon. 36(11). 1671–1682. 28 indexed citations
18.
Gershburg, Edward, et al.. (1998). Baculovirus‐mediated expression of a scorpion depressant toxin improves the insecticidal efficacy achieved with excitatory toxins. FEBS Letters. 422(2). 132–136. 61 indexed citations
19.
Gershburg, Edward, et al.. (1997). Expression of the Autographa californica nuclear polyhedrosis virus apoptotic suppressor gene p35 in nonpermissive Spodoptera littoralis cells. Journal of Virology. 71(10). 7593–7599. 17 indexed citations
20.
Chejanovsky, Nor & Edward Gershburg. (1995). The Wild-Type Autographa californica Nuclear Polyhedrosis Virus Induces Apoptosis of Spodoptera littoralis Cells. Virology. 209(2). 519–525. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriko Shirata Breakdown of academic impact, for papers by Satoko Iwahori Breakdown of academic impact, for papers by Wilma P. Summers Breakdown of academic impact, for papers by Shihua Lu Breakdown of academic impact, for papers by Harinivas H. Krishnan Breakdown of academic impact, for papers by Sanae Nakayama Breakdown of academic impact, for papers by Gregory S. Pari Breakdown of academic impact, for papers by Mira S. Chaurushiya Breakdown of academic impact, for papers by Daniëlle Horst Breakdown of academic impact, for papers by Li–Rung Huang
Rankless by CCL
2026